Advertisement
Advertisement
ODTX
Odyssey Therapeutics, Inc. Common Stock
18.47
USDSponsored
-0.08
-0.43%
Jun 24, 16:00 UTC -4
Closed
Pre-Market
20.14
+1.67
+9.04%
ODTX Earnings Reports
Positive Surprise Ratio
ODTX beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Odyssey Therapeutics, Inc. Common Stock earnings per share and revenue
On Jun 17, 2026, ODTX reported earnings of -6.77 USD per share (EPS) for Q1 26, missing the estimate of -1.27 USD, resulting in a -429.90% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.19% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Aimei Health Technology Co., Ltd Ordinary Share
Report Date
Jun 16, 2026 For Q1 26
Estimate
-Actual
$0.01
Surprise
-
Suncrete, Inc. Class A Common Stock
Report Date
Jun 24, 2026 For Q1 26
Estimate
$0.04
Actual
-$0.06
Surprise
-247.06%
Aimei Health Technology Co., Ltd Unit
Report Date
Jun 16, 2026 For Q1 26
Estimate
-Actual
$0.01
Surprise
-
Cerebras Systems Inc. Class A Common Stock
Report Date
Jun 23, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.04
Surprise
+75.67%
Sunbelt Rentals Holdings, Inc.
Report Date
Jun 23, 2026 For Q4 26
Estimate
$0.75
Actual
$0.74
Surprise
-2.54%
Fervo Energy Company Class A common stock
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$0.07
Actual
-$3.72
Surprise
-5169.12%
HawkEye 360, Inc.
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.44
Surprise
-684.31%
FAQ
What were Odyssey Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Odyssey Therapeutics, Inc. Common Stock reported EPS of -$6.77, missing estimates by -429.9%, and revenue of $0.00, 0% as expectations.
How did the market react to Odyssey Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 3.19%, changed from $18.48 before the earnings release to $19.07 the day after.
When is Odyssey Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Odyssey Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Odyssey Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement